Skip to main content

Table 1 Baseline characteristics of patients with pancreatic ductal adenocarcinoma (n = 138)

From: Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma

Factors n (%) Median (IQR) Missing
Age at diagnosis (years)   68.5 (63.0–73.0)  
Gender (female) 73 (52.9)   
Size of primary tumor (cm)   3.0 (2.5–4.0)  
T stage
- T1 19 (13.8)   
- T2 92 (66.7)   
- T3 26 (18.8)   
- T4 1 (0.7)   
N stage    0.7%
- N0 34 (26.4)   
- N1 52 (37.7)   
- N2 51 (37.0)   
AJCC stage, eighth edition    0.7%
- IA 6 (4.3)   
- IB 20 (14.5)   
- IIA 7 (5.1)   
- IIB 52 (37.7)   
- III 52 (37.7)   
Tumor differentiation    0.7%
- Well 7 (5.1)   
- Moderate 48 (34.8)   
- Poor 78 (56.5)   
- Anaplastic 4 (2.9)   
Positive resection margin (≥R1) 53 (38.4)   
Adjuvant chemotherapy 111 (80.4)   3.6%
  1. Abbreviations: AJCC American Joint Committee on Cancer